135 related articles for article (PubMed ID: 21905944)
1. Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.
Hoenigl M; Salzer HJ; Raggam RB; Valentin T; Rohn A; Woelfler A; Seeber K; Linkesch W; Krause R
Med Mycol; 2012 Apr; 50(3):266-9. PubMed ID: 21905944
[TBL] [Abstract][Full Text] [Related]
2. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
[TBL] [Abstract][Full Text] [Related]
3. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.
Hoenigl M; Seeber K; Koidl C; Buzina W; Wölfler A; Duettmann W; Wagner J; Strenger V; Krause R
Mycoses; 2013 Jul; 56(4):471-6. PubMed ID: 23432536
[TBL] [Abstract][Full Text] [Related]
5. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
[TBL] [Abstract][Full Text] [Related]
6. Serum and urine galactomannan testing for screening in patients with hematological malignancies.
Duettmann W; Koidl C; Troppan K; Seeber K; Buzina W; Wölfler A; Wagner J; Krause R; Hoenigl M
Med Mycol; 2014 Aug; 52(6):647-52. PubMed ID: 24939321
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
[TBL] [Abstract][Full Text] [Related]
8. [Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients].
Jarque I; Andreu R; Salavert M; Gómez D; Pemán J; Gobernado M; Sanz MA
Rev Iberoam Micol; 2003 Sep; 20(3):116-8. PubMed ID: 15456368
[TBL] [Abstract][Full Text] [Related]
9. Urine Galactomannan-to-Creatinine Ratio for Detection of Invasive Aspergillosis in Patients with Hematological Malignancies.
Reischies FM; Raggam RB; Prattes J; Krause R; Eigl S; List A; Quehenberger F; Strenger V; Wölfler A; Hoenigl M
J Clin Microbiol; 2016 Mar; 54(3):771-4. PubMed ID: 26699701
[TBL] [Abstract][Full Text] [Related]
10. Galactomannan antigenemia for the diagnosis of invasive aspergillosis in neutropenic patients with hematological disorders.
Suankratay C; Kanitcharaskul P; Arunyingmongkol K
J Med Assoc Thai; 2006 Nov; 89(11):1851-8. PubMed ID: 17205865
[TBL] [Abstract][Full Text] [Related]
11. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
[TBL] [Abstract][Full Text] [Related]
12. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients.
Buchheidt D; Hummel M; Schleiermacher D; Spiess B; Schwerdtfeger R; Cornely OA; Wilhelm S; Reuter S; Kern W; Südhoff T; Mörz H; Hehlmann R
Br J Haematol; 2004 Apr; 125(2):196-202. PubMed ID: 15059142
[TBL] [Abstract][Full Text] [Related]
13. [Combination of real-time polymerase chain reaction assay and serum galactomannan in the diagnosis of invasive aspergillosis in patients with hematological malignancies and recipients of hematopoietic stem cell transplantation].
Sun YQ; Ji Y; Xu LP; Liu DH; Liu KY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):375-8. PubMed ID: 20367932
[TBL] [Abstract][Full Text] [Related]
14. Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients.
Choi SH; Kang ES; Eo H; Yoo SY; Kim JH; Yoo KH; Sung KW; Koo HH; Kim YJ
Pediatr Blood Cancer; 2013 Feb; 60(2):316-22. PubMed ID: 23042761
[TBL] [Abstract][Full Text] [Related]
15. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma.
Mori Y; Nagasaki Y; Kamezaki K; Takenaka K; Iwasaki H; Harada N; Miyamoto T; Abe Y; Shimono N; Akashi K; Teshima T
Am J Hematol; 2010 Jun; 85(6):449-51. PubMed ID: 20513124
[TBL] [Abstract][Full Text] [Related]
16. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.
Cordonnier C; Botterel F; Ben Amor R; Pautas C; Maury S; Kuentz M; Hicheri Y; Bastuji-Garin S; Bretagne S
Clin Microbiol Infect; 2009 Jan; 15(1):81-6. PubMed ID: 19154482
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Serum Galactomannan Test Results of Pediatric Patients With Hematologic Malignancies According to Consecutive Positivity and Threshold Level in Terms of Invasive Aspergillosis Diagnosis: Cross-Sectional Research in a Tertiary Care Hospital.
Çağlar İ; Özkerim D; Tahta N; Düzgöl M; Bayram N; Demirağ B; Karapinar TH; Sorguç Y; Gözmen S; Dursun V; Oymak Y; Vergin C; Devrim İ
J Pediatr Hematol Oncol; 2020 Jul; 42(5):e271-e276. PubMed ID: 31725542
[TBL] [Abstract][Full Text] [Related]
18. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients.
Botterel F; Farrugia C; Ichai P; Costa JM; Saliba F; Bretagne S
Transpl Infect Dis; 2008 Oct; 10(5):333-8. PubMed ID: 18627580
[TBL] [Abstract][Full Text] [Related]
19. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
